Dashboard
Manage Tickers

XCUR EXICURE, INC.

Nasdaq exicuretx.com


$ 4.56 $ -0.36 (-7.35 %)    

Friday, 17-Oct-2025 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 4.54
$ 4.83
$ 4.50 x 1
$ 5.59 x 639
$ 4.48 - $ 4.98
$ 2.33 - $ 36.00
31,513
na
28.68M
$ 1.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2025 06-30-2025 10-Q
2 06-27-2025 03-31-2025 10-Q
3 03-18-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 06-17-2024 03-31-2024 10-Q
7 06-06-2024 12-31-2023 10-K
8 05-16-2024 09-30-2023 10-Q
9 08-11-2023 06-30-2023 10-Q
10 07-14-2023 03-31-2023 10-Q
11 03-27-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-15-2022 06-30-2022 10-Q
14 05-16-2022 03-31-2022 10-Q
15 03-25-2022 12-31-2021 10-K
16 11-19-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-12-2020 09-30-2020 10-Q
21 08-12-2020 06-30-2020 10-Q
22 05-14-2020 03-31-2020 10-Q
23 03-10-2020 12-31-2019 10-K
24 11-07-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-08-2019 03-31-2019 10-Q
27 03-08-2019 12-31-2018 10-K
28 11-06-2018 09-30-2018 10-Q
29 08-06-2018 06-30-2018 10-Q
30 05-15-2018 03-31-2018 10-Q
31 03-09-2018 12-31-2017 10-K
32 11-14-2017 09-30-2017 10-Q
33 09-12-2017 08-31-2017 10-Q
34 07-11-2017 05-31-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

exicure-says-ongoing-phase-2-study-of-burixafor-in-autologous-stem-cell-transplant-for-multiple-myeloma-nears-key-readout
Exicure Says Ongoing Phase 2 Study Of Buri...
10/06/2025 11:04:39

Burixafor Phase 2 Trial in Multiple Myeloma Nears Key Clinical ReadoutExicure's ongoing Phase 2 study (NCT05561751) is a ra...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 21:06:02

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/11/2025 17:06:18

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
08/11/2025 12:08:21

exicure-says-management-believes-that-the-companys-existing-cash-and-cash-equivalents-is-not-sufficient-to-continue-to-fund-operations-says-substantial-additional-financing-is-needed-in-short-term
Exicure Says 'Management believes that the...
08/08/2025 20:03:17

exicure-q2-eps-041-down-from-035-yoy
Exicure Q2 EPS $(0.41) Down From $(0.35) YoY
08/08/2025 20:02:16

Exicure (NASDAQ:XCUR) reported quarterly losses of $(0.41) per share. This is a 17.14 percent decrease over losses of $(0.35) p...

exicure-regains-nasdaq-compliance
Exicure Regains Nasdaq Compliance
08/04/2025 20:38:42

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/01/2025 21:06:34

exicure-completes-phase-2-trial-of-gpc-100-for-stem-cell-mobilization-in-multiple-myeloma-topline-results-expected-q4-2025
Exicure Completes Phase 2 Trial Of GPC-100...
08/01/2025 20:03:24

Topline results expected H2 2025Exicure, Inc. (NASDAQ:XCUR), a clinical-stage biotechnology company developing therapeutics for...

exicure-files-for-prospectus-offering-52m-common-stock-offered-by-selling-stockholders
Exicure Files For Prospectus Offering 5.2M...
07/14/2025 15:47:30

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 17:05:56

Core News & Articles
12 Health Care Stocks Moving In Tuesday's ...
07/01/2025 12:07:35

progress-software-exicure-and-3-stocks-to-watch-heading-into-monday
Progress Software, Exicure And 3 Stocks To...
06/30/2025 08:35:23

U.S. stock futures up, focus on PRGS, XCUR, QMCO earnings. VERO jumps 43.6% after stake increase, IGC reports positive results...

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
06/27/2025 21:05:51

exicure-q1-eps-049-up-from-048-yoy
Exicure Q1 EPS $0.49 Up From $(0.48) YoY
06/27/2025 20:02:20

Exicure (NASDAQ:XCUR) reported quarterly earnings of $0.49 per share. This is a 202.08 percent increase over losses of $(0.48) ...

exicure-receives-nasdaq-delinquencyletter-regarding-late-filing-of-its-form-10-q
Exicure Receives Nasdaq DelinquencyLetter ...
05/28/2025 21:00:59

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
04/21/2025 17:05:41

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
04/17/2025 21:05:38

reported-earlier-exicure-nears-completion-of-phase-2-trial-of-gpc-100-in-multiple-myeloma-doses-19th-patient-in-stem-cell-mobilization-study
Reported Earlier, Exicure Nears Completion...
04/15/2025 07:33:37

reported-friday-exicure-advances-gpc-100-into-aml-with-new-trial-plans-building-on-prior-chemosensitization-study
Reported Friday, Exicure Advances GPC-100 ...
04/14/2025 06:25:06

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION